NCT03068403View on ClinicalTrials.gov

Dynamic Contrast Enhanced Ultrasound for Predict and Assess Rectal Cancer Response After Neo-adjuvant Chemoradiation - RECT

NACompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

June 18, 2018

Primary Completion Date

November 8, 2018

Study Completion Date

January 8, 2019

Conditions
Rectal Cancer
Interventions
PROCEDURE

Dynamic contrast enhanced ultrasound (D-CEUS) with Sonovue® administration

Dynamic contrast enhanced ultrasound (D-CEUS) with Sonovue® administration

Trial Locations (1)

Unknown

CHU de Bordeaux, Bordeaux

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT03068403 - Dynamic Contrast Enhanced Ultrasound for Predict and Assess Rectal Cancer Response After Neo-adjuvant Chemoradiation - RECT | Biotech Hunter | Biotech Hunter